Craig Venter says his company has uncovered disease in people who otherwise appeared healthy, HealthcareITNews reports.
Researchers have argued that the facial prediction claims are overblown and serve Human Longevity's financial interests in proprietary genomic databases.
In PNAS this week: trait prediction algorithm, missense mutation linked to hearing loss, and more.
Using a new algorithm, JCVI and Human Longevity researchers revealed potential re-identification risks using trait prediction from genome sequences.
The companies are aiming to identify treatment-response biomarker signatures in patients with advanced melanoma.
In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.
Massachusetts Mutual Life Insurance-associated patients can have their doctor order the HLIQ Whole Genome sequencing test for $1,400.
This month, GWG Life began sending out cheek swab kits to life insurance policy holders to analyze their saliva for epigenetic biomarkers developed at UCLA.
A GWAS of blood metabolite patterns in identical and non-identical twins led to common, low-frequency, and rare variants influencing metabolite levels
In PNAS this week: mutation patterns in uterine and ovarian carcinosarcomas, deep genome sequences, and more.
Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.
The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.
CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.
In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.